Insulet Corp.

PODD ·Healthcare, Medical Devices, United States

Net Cash Flow Breakdown

FY2025 FY2024 FY2023 FY2022 FY2020 FY2019 FY2018 FY2017 FY2016 FY2014 FY2013

Total Cash from Operations: $722.4M

Line Item	Value	% of Total
Working Capital	$14.1M	2.0%
Net Cash Flow	$708.3M	98.0%